| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.24B | +54.4% |
| Cost of Revenue | $601.2M | +56.9% |
| Gross Profit | $1.64B | +53.5% |
| R&D Expense | $608.4M | +63.9% |
| SG&A Expense | $317.3M | +42.2% |
| Operating Income | -$190.1M | -33.4% |
| Interest Expense | $25.3M | +0.3% |
| Pre-tax Income | -$159.9M | +0.1% |
| Income Tax | $22.4M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.46B | +23.0% |
| Short-term Investments | $250.0M | — |
| Accounts Receivable | $626.2M | +70.1% |
| Current Assets | $3.64B | +41.6% |
| Total Assets | $5.03B | +38.9% |
| Current Liabilities | $2.11B | +49.9% |
| Long-term Debt | $741.0M | +0.2% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $941.0M | +63.7% |
| Capital Expenditures | $235.0M | +109.6% |
| Investing Cash Flow | -$556.7M | +1.4% |
| Financing Cash Flow | $77.4M | +6.8% |
| Free Cash Flow | $706.0M | +52.6% |
| -69.0% |
| Net Income | -$183.2M | +22.0% |
| EPS (Basic) | -$0.79 | +23.3% |
| EPS (Diluted) | -$0.79 | +23.3% |
| Total Liabilities |
| $3.54B |
| +37.1% |
| Stockholders' Equity | $1.46B | +42.7% |